Avantor appoints former GSK CFO Simon Dingemans to board effective Jan 2, 2026

Avantor, Inc.

Simon Dingemans elected to board effective Jan 2, 2026, filling vacancy from Jonathan Peacock's Dec 31, 2025 resignation.
Dingemans served as CFO of GSK (2011-2019) and as Managing Director/Partner at Carlyle Group (2020-2022).
Standard non-employee director compensation: $95K annual cash retainer plus $210K RSU grant vesting May 6, 2026.
Dingemans also serves on boards of Vodafone Group, WPP plc, and Genomics Limited.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.